ReviewJournal for immunotherapy of cancer2019

Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations.

Amalia Anastasopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.